We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

49 hedge funds and large institutions have $7.92M invested in TherapeuticsMD in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

44% more capital invested

Capital invested by funds: $5.52M → $7.92M (+$2.4M)

11% more funds holding

Funds holding: 44 → 49 (+5)

4.71% more ownership

Funds ownership: 29.25% → 33.96% (+4.7%)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

Holders
49
Holders Change
+5
Holders Change %
+11.36%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
9
Closed
3
Calls
$105K
Puts
–
Net Calls
+$105K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
SCM
Squadron Capital Management
Illinois
+$945K
2
Renaissance Technologies
Renaissance Technologies
New York
+$112K
3
Citadel Advisors
Citadel Advisors
Florida
+$90.1K
4
XT
XTX Topco
Cayman Islands
+$61.8K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$24.1K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$31.4K
2
Osaic Holdings
Osaic Holdings
Arizona
-$20.6K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.5K
4
TC
Tejara Capital
United Kingdom
-$11.2K
5
Group One Trading
Group One Trading
Illinois
-$3.58K
Name Holding Trade Value Shares
Change 		Change in
Stake
US Bancorp
26
US Bancorp
Minnesota
$497 – – –
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$457 – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$308 -$20.6K -9,144 -98%
HNB
29
Huntington National Bank
Ohio
$242 – – –
Wells Fargo
30
Wells Fargo
California
$232 +$175 +78 +211%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$103 -$18.5K -8,239 -99%
AWM
32
Activest Wealth Management
Florida
$81 – – –
SPIA
33
Steward Partners Investment Advisory
New York
$71 – – –
FFA
34
Farther Finance Advisors
California
$62 +$2 +1 +3%
IA
35
IFP Advisors
Florida
$42 – – –
Carson Wealth (CWM LLC)
36
Carson Wealth (CWM LLC)
Nebraska
$40 – – –
PWA
37
Provenance Wealth Advisors
Florida
$40 – – –
TC
38
Truvestments Capital
Florida
$20 – – –
CCA
39
Cygnus Capital Advisors
Georgia
$18 +$20.4K +9,069 New
HI
40
Harbour Investments
Wisconsin
$16 – – –
AssetMark Inc
41
AssetMark Inc
California
$8 – – –
ASN
42
Advisory Services Network
Georgia
$8 +$9 +4 New
Group One Trading
43
Group One Trading
Illinois
$4 -$3.58K -1,594 -100%
SWIM
44
Smallwood Wealth Investment Management
New Jersey
$4 – – –
BWL
45
Bogart Wealth LLC
Virginia
$4 +$4 +2 New
JFGIW
46
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$3 +$2 +1 New
EWA
47
EverSource Wealth Advisors
Alabama
$2 – – –
Bank of America
48
Bank of America
North Carolina
– -$176 -108 Closed
Citigroup
49
Citigroup
New York
– -$2 -1 Closed
SA
50
Strategic Advocates
Utah
– -$2 -1 Closed
1
2
3

TXMD Hedge Fund Activity: Q1 2026 in Review

49 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2026, worth a combined $7.92M — up 44% from $5.52M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TXMD positions and 3 closed out — a net gain of 7 holders — while 7 added to existing stakes and 9 trimmed.

The largest buyer was Squadron Capital Management, opening a new position worth an estimated $945K. The largest seller was Susquehanna International Group, cutting an estimated $31.4K.

  • 49 institutional investors held TherapeuticsMD (TXMD) as of Q1 2026, up from 44 in Q4 2025.
  • Funds reported $7.92M of TherapeuticsMD stock for Q1 2026, up 44% quarter-over-quarter.
  • 10 funds opened new TherapeuticsMD positions in Q1 2026 and 3 closed out, a net change of +7 holders.
  • The largest TherapeuticsMD buyer in Q1 2026 was Squadron Capital Management, an estimated $945K added.
  • The largest TherapeuticsMD seller in Q1 2026 was Susquehanna International Group, an estimated $31.4K sold.

Based on aggregated 13F filings for Q1 2026.